X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA VENUS REMEDIES ELDER PHARMA/
VENUS REMEDIES
 
P/E (TTM) x -0.2 -804.4 - View Chart
P/BV x 0.1 0.2 42.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
VENUS REMEDIES
Mar-16
ELDER PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs380218 174.3%   
Low Rs18882 229.0%   
Sales per share (Unadj.) Rs491.2365.6 134.3%  
Earnings per share (Unadj.) Rs-3.21.5 -214.1%  
Cash flow per share (Unadj.) Rs14.437.9 38.0%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.5382.5 98.4%  
Shares outstanding (eoy) m20.5411.44 179.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.60.4 140.9%   
Avg P/E ratio x-89.3101.0 -88.4%  
P/CF ratio (eoy) x19.74.0 498.1%  
Price / Book Value ratio x0.80.4 192.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8331,717 339.8%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m2,179324 671.7%   
Avg. sales/employee Rs ThNM4,100.7-  
Avg. wages/employee Rs ThNM318.0-  
Avg. net profit/employee Rs ThNM16.7-  
INCOME DATA
Net Sales Rs m10,0894,183 241.2%  
Other income Rs m25720 1,276.6%   
Total revenues Rs m10,3464,203 246.2%   
Gross profit Rs m-792812 -97.6%  
Depreciation Rs m361417 86.7%   
Interest Rs m2,756380 725.7%   
Profit before tax Rs m-3,65335 -10,407.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m12518 691.4%   
Profit after tax Rs m-6517 -384.4%  
Gross profit margin %-7.819.4 -40.5%  
Effective tax rate %-3.451.6 -6.6%   
Net profit margin %-0.60.4 -159.4%  
BALANCE SHEET DATA
Current assets Rs m9,2402,771 333.5%   
Current liabilities Rs m9,9981,931 517.6%   
Net working cap to sales %-7.520.1 -37.4%  
Current ratio x0.91.4 64.4%  
Inventory Days Days46125 37.0%  
Debtors Days Days6054 111.5%  
Net fixed assets Rs m10,1245,328 190.0%   
Share capital Rs m206114 179.8%   
"Free" reserves Rs m5,5824,177 133.6%   
Net worth Rs m7,7344,376 176.7%   
Long term debt Rs m4,8891,911 255.9%   
Total assets Rs m22,8828,428 271.5%  
Interest coverage x-0.31.1 -29.8%   
Debt to equity ratio x0.60.4 144.8%  
Sales to assets ratio x0.40.5 88.8%   
Return on assets %11.84.7 249.8%  
Return on equity %-0.80.4 -217.5%  
Return on capital %22.36.6 338.1%  
Exports to sales %3.00-   
Imports to sales %0.420.5 2.1%   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43858 5.0%   
Fx inflow Rs m3070-   
Fx outflow Rs m125858 14.6%   
Net fx Rs m181-858 -21.1%   
CASH FLOW
From Operations Rs m11,754469 2,507.3%  
From Investments Rs m-56129 -1,919.5%  
From Financial Activity Rs m-6,762-464 1,458.9%  
Net Cashflow Rs m4,43235 12,845.5%  

Share Holding

Indian Promoters % 39.6 32.9 120.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 0.2 4,166.7%  
FIIs % 16.8 0.6 2,896.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 66.4 54.4%  
Shareholders   16,479 20,121 81.9%  
Pledged promoter(s) holding % 77.6 36.4 213.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 200 Points Higher; Lupin & Axis Bank Top Gainers(09:30 am)

Majority of Asian stock indices are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.07%, while the Hang Seng is up 1.06%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - JUBILANT LIFE SCIENCES COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS